CORRESP 1 filename1.htm

 

February 1, 2018

 

 

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Mail Stop 4546

 

Attn: Irene Paik

 

Re:CASI Pharmaceuticals, Inc.

Registration Statement on Form S-3

File No. 333-222701

Request for Acceleration                    

 

Ladies and Gentlemen:

 

CASI Pharmaceuticals, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission accelerate the effective date of the referenced Registration Statement on Form S-3 so that it may become effective at 4:00 p.m. Eastern Time on February 5, 2018, or as soon thereafter as practicable.

 

  

       
 

Very truly yours,

 

CASI PHARMACEUTICALS, INC.

     
  By:   /s/ Cynthia W. Hu
     

Name: Cynthia W. Hu

Title: Chief Operating Officer